| Metrics | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenue & Cost | |||
| Total Revenue | $120.30M | $2.47B | $2.50B |
| Cost of Revenue | $0.00 | $0.00 | - |
| Gross Profit | $0.00 | $2.47B | $2.50B |
| Gross Margin % | 0.00% | 100.00% | 100.00% |
| Operating Expenses | |||
| R&D Expenses | $0.00 | - | - |
| SG&A Expenses | $0.00 | $766.63M | $785.46M |
| Other Operating Expenses | $0.00 | $-750.19M | - |
| Total Operating Expenses | $0.00 | $16.44M | $1.11B |
| Operating Performance | |||
| Operating Income | $0.00 | $1.05B | $1.09B |
| Operating Margin % | 0.00% | 42.40% | 43.64% |
| EBITDA | $168.98M | $1.08B | - |
| EBITDA Margin % | 140.46% | 43.70% | - |
| Other Income/Expenses | |||
| Interest Expense | $0.00 | $250.45M | $1.29B |
| Other Income/Expenses Net | $0.00 | $-250.45M | $-6.50M |
| Income Before Tax | $0.00 | $797.98M | $1.08B |
| Income Tax Expense | $0.00 | $153.69M | $216.66M |
| Net Performance | |||
| Net Income | $0.00 | $644.28M | $867.84M |
| Net Margin % | 0.00% | 26.06% | 34.71% |
| EPS | $0.00 | $3.72 | $4.91 |
| Diluted EPS | $0.00 | $3.72 | $4.91 |
| Metrics | 2021 | 2022 | 2023 |
|---|---|---|---|
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | $137.39M | $839.94M | $1.72B |
| Short Term Investments | - | $7.89B | $-14.18B |
| Net Receivables | $531.47M | $1.62B | - |
| Inventory | - | - | - |
| Other Current Assets | $-137.39M | $-575.83M | $2.05B |
| Total Current Assets | $531.47M | $9.77B | $3.54B |
| Non-Current Assets | |||
| Property, Plant & Equipment (Net) | - | $430.18M | $429.56M |
| Long Term Investments | - | $14.46B | $16.03B |
| Tax Assets | $109.41M | $371.63M | $582.70M |
| Other Non-Current Assets | - | $-14.46B | $-19.88B |
| Total Non-Current Assets | $665.65M | $3.52B | $87.29B |
| Total Assets | |||
| Total Assets | $9.00K | $71.28B | $74.95B |
| Liabilities | |||
| Current Liabilities | |||
| Accounts Payable | - | - | - |
| Short Term Debt | - | $6.64B | - |
| Tax Payables | $-22.58M | - | - |
| Deferred Revenue | - | - | - |
| Other Current Liabilities | - | $27.79B | - |
| Total Current Liabilities | - | $34.43B | $36.61B |
| Non-Current Liabilities | |||
| Long Term Debt | $562.93M | $6.53B | $3.41B |
| Other Non-Current Liabilities | - | $-5.46B | $-2.36B |
| Total Non-Current Liabilities | $562.93M | $1.07B | $1.05B |
| Total Liabilities | |||
| Total Liabilities | $31.48B | $63.22B | $66.26B |
| Shareholders Equity | |||
| Equity Components | |||
| Common Stock | $55.00K | $7.77B | $1.83M |
| Retained Earnings | $2.33B | $2.71B | $3.28B |
| Accumulated Other Comprehensive Income/Loss | $-22.58M | $-684.96M | $-550.57M |
| Total Shareholders Equity | $3.44B | $8.06B | $8.69B |
| Key Metrics | |||
| Balance Check | |||
| Total Liabilities & Equity | $34.92B | $71.28B | $74.95B |
| Total Debt | $562.93M | $6.53B | $3.41B |
| Net Debt | $425.55M | $5.69B | $1.69B |
| Metrics | 2021 | 2022 | 2023 |
|---|---|---|---|
| Operating Activities | |||
| Core Operations | |||
| Net Income | - | $644.28M | $859.92M |
| Depreciation & Amortization | $168.98M | $82.67M | $70.91M |
| Stock Based Compensation | $13.66M | $54.10M | $54.09M |
| Working Capital Changes | |||
| Change in Accounts Receivable | - | $-106.74M | $-13.77M |
| Change in Inventory | - | - | - |
| Change in Accounts Payable | - | - | - |
| Other Working Capital Changes | $531.47M | $415.26M | $-189.38M |
| Total Working Capital Change | $510.95M | $308.52M | $-203.15M |
| Other Operating | |||
| Other Non-Cash Items | - | $271.83M | $250.82M |
| Net Cash from Operations | $688.59M | $1.34B | $978.95M |
| Investing Activities | |||
| Capital Investments | |||
| Capital Expenditures | $3.22M | $-28.76M | $-40.30M |
| Purchase of Investments | $-1.96B | $-2.27B | $-3.29B |
| Sale of Investments | $935.62M | $1.68B | $1.77B |
| Other Investing Activities | $-1.39B | $-7.02B | $-888.47M |
| Net Cash from Investing | $-2.41B | $-7.19B | $-2.60B |
| Financing Activities | |||
| Debt & Equity | |||
| Debt Repayment | - | $-22.00B | $-3.81B |
| Stock Repurchases | - | $-322.10M | $-124.26M |
| Dividends Paid | - | $-261.49M | $-294.81M |
| Other Financing Activities | - | $28.81B | $6.72B |
| Net Cash from Financing | - | $6.23B | $2.49B |
| Cash Position | |||
| Summary | |||
| Net Change in Cash | $-14.43M | $378.37M | $875.85M |
| Cash at Beginning of Period | - | $461.57M | $839.94M |
| Cash at End of Period | - | $839.94M | $1.72B |
| Key Metrics | |||
| Operating Cash Flow | $688.59M | $1.34B | $978.95M |
| Capital Expenditure | $3.22M | $-28.76M | $-40.30M |
| Free Cash Flow | $691.81M | $1.31B | $938.64M |